Evidence-based protocol for diabetic foot ulcers

Plastic and Reconstructive Surgery

Volumn 117, Issue 7 SUPPL., 2006, Pages

  Brem, Harold ^a   Sheehan, Peter ^a   Rosenberg, Harvey J ^a   Schneider, Jillian S ^a   Boulton, Andrew J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BECAPLERMIN; CADEXOMER IODINE; CHOLESTEROL; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; HEMOGLOBIN A1C; HYDROGEN PEROXIDE; ITRACONAZOLE; KETOCONAZOLE; PLATELET DERIVED GROWTH FACTOR; POVIDONE IODINE; SILVER NITRATE; SULFADIAZINE SILVER; TERBINAFINE; GROWTH PROMOTOR;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ANTIBIOTIC THERAPY; ARTERY DISEASE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BIOLOGICAL THERAPY; CALLUS; CELLULITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; EUROPE; EVIDENCE BASED MEDICINE; HEART DISEASE; HUMAN; KIDNEY DISEASE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MICROALBUMINURIA; ONYCHOMYCOSIS; OSTEOMYELITIS; PHYSICIAN; PRIORITY JOURNAL; RETINOPATHY; REVIEW; UNITED STATES; VASCULARIZATION; WOUND ASSESSMENT; WOUND CARE; WOUND DRESSING; WOUND HEALING; BANDAGE; COST; ECONOMICS; HUMIDITY; LEG; METHODOLOGY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSIOLOGY; PLASTER CAST; SKIN DISEASE; VACUUM; WEIGHT BEARING;

ANTI-BACTERIAL AGENTS; BANDAGES; CASTS, SURGICAL; CLINICAL PROTOCOLS; COSTS AND COST ANALYSIS; DEBRIDEMENT; DIABETIC FOOT; EVIDENCE-BASED MEDICINE; FOOT DERMATOSES; GROWTH SUBSTANCES; HUMANS; HUMIDITY; LOWER EXTREMITY; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; ONYCHOMYCOSIS; OSTEOMYELITIS; PATIENT CARE TEAM; VACUUM; WEIGHT-BEARING; WOUND HEALING;

EID: 33745492980     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000225459.93750.29     Document Type: Review

References (161)

1. Wild, S., Roglic, G., Green, A., et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047, 2004.
2. Singh, N., Armstrong, D. G., and Lipsky, B. A. Preventing foot ulcers in patients with diabetes. J.A.M.A. 293: 217, 2005.
3. International Diabetes Federation. Time to Act: Diabetes and Foot Care. Brussels: International Diabetes Federation, 2005.
4. Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., et al. The global burden of diabetic foot disease. Lancet 366: 1719, 2005.
5. Centers for Disease Control. National Estimates on Diabetes, 2000-2001. Publications and products, national diabetes fact sheet. Available at: http://www.cdc.gov/diabetes/pubs/estimates.htm. Accessed January 17, 2006.
6. Centers for Disease Control. Hospitalizations for Non-traumatic Lower Extremity Amputation, 1980-2002. Data and trends, National Diabetes Surveillance System. Available at: http://www.cdc.gov/diabetes/statistics/lea/byAgetable1_2. htm. Accessed January 17, 2006.
7. Campbell, L. V., Graham, A. R., Kidd, R. M., et al. The lower limb in people with diabetes: Position statement of the Australian Diabetes Society. Med. J. Aust. 173: 369, 2000.
8. Rieber, G. E., Boyko, E. J., and Smith, D. G. Lower extremity foot ulcers and amputations in diabetes. In M. I. Harris, C. Cowie, and M. P. Stern (Eds.), Diabetes in America. Washington, D.C.: U.S. Government Printing Office, 1995.
9. Morris, A. D., McAlpine, R., Steinke, D., et al. Diabetes and lower-limb amputations in the community: A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 21: 738, 1998.
10. Boulton, A. J. The diabetic foot: A global view. Diabetes Metab. Res. Rev. 16 (Suppl. 1): S2, 2000.
11. Larsson, J., Apelqvist, J., Agardh, C. D., et al. Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach? Diabet. Med. 12: 770, 1995.
12. Pecoraro, R. E., Reiber, G. E., and Burgess, E. M. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care 13: 513, 1990.
13. Mayfield, J. A., Reiber, G. E., Sanders, L. J., et al. Preventive foot care in people with diabetes. Diabetes Care 26 (Suppl. 1): S78, 2003.
14. Tesfaye, S., Chaturvedi, N., Eaton, S. E., et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352: 341, 2005.
15. Centers for Disease Control and Prevention. History of foot ulcer among persons with diabetes: United States 2000-2002. M.M.W.R. Morb. Mort. Wkly. Rep. 52: 1098, 2003.
16. Bessman, A. N., and Sapico, F. L. Infections in the diabetic patient: The role of immune dysfunction and pathogen virulence factors. J. Diabetes Complications 4: 258, 1996.
17. van den Biggelaar, A. H., Huizinga, T. W., de Craen, A. J., et al. Impaired innate immunity predicts frailty in old age: The Leiden 85-plus study. Exp. Gerontol. 39: 1407, 2004.
18. Colonna-Romano, G., Aquino, A., Bulati, M., et al. Impairment of gamma/delta T lymphocytes in elderly: Implications for immunosenescence. Exp. Gerontol. 39: 1439, 2004.
19. Falanga, V. Wound healing and its impairment in the diabetic foot. Lancet 366: 1736, 2005.
20. Stojadinovic, O., Brem, H., Vouthounis, C., et al. Molecular pathogenesis of chronic wounds: The role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167: 59, 2005.
21. Bowering, C. K. Diabetic foot ulcers: Pathophysiology, assessment, and therapy. Can. Fam. Phys. 47: 1007, 2001.
22. Armstrong, D. G., Attinger, C. E., Boulton, A. J., et al. Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy Wound Manage. 50: 3S, 2004.
23. Boulton, A. J., Meneses, P., and Ennis, W. J. Diabetic foot ulcers: A framework for prevention and care. Wound Repair Regen. 7: 7, 1999.
24. Millington, J. T., and Norris, T. W. Effective treatment strategies for diabetic foot wounds. J. Fam. Pract. 49: S40, 2000.
25. Steed, D. L., Donohoe, D., Webster, M. W., et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers: Diabetic Ulcer Study Group. J. Am. Coll. Surg. 183: 61, 1996.
26. Brem, H., Balledux, J., Bloom, T., et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch. Surg. 135: 627, 2000.
27. Brem, H., Sheehan, P., and Boulton, A. J. Protocol for treatment of diabetic foot ulcers. Am. J. Surg. 187: 1S, 2004.
28. Hogan, P., Dall, T., and Nikolov, P. Economic costs of diabetes in the US in 2002. Diabetes Care 26: 917, 2003.
29. Ramsey, S. D., Newton, K., Blough, D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382, 1999.
30. Eckman, M. H., Greenfield, S., Mackey, W. C., et al. Foot infections in diabetic patients: Decision and cost-effectiveness analyses. J.A.M.A. 273: 712, 1995.
31. Ribu, L., and Wahl, A. Living with diabetic foot ulcers: A life of fear, restrictions, and pain. Ostomy Wound Manage. 50: 57, 2004.
32. Arora, S., Pomposelli, F., LoGerfo, F. W., et al. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J. Vasc. Surg. 35: 501, 2002.
33. American Diabetes Association. Preventive foot care in people with diabetes. Foot Ankle Int. 21: 76, 2000.
34. Kamei, N., Yamane, K., Nakanishi, S., et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J. Diabetes Complications 19: 47, 2005.
35. Mayfield, J. A., and Sugarman, J. R. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J. Fam. Pract. 49: S17, 2000.
36. Ulbrecht, J. S., Cavanagh, P. R., and Caputo, G. M. Foot problems in diabetes: An overview. Clin. Infect. Dis. 39 (Suppl. 2): S73, 2004.
37. Tassler, P. L., and Dellon, A. L. Pressure perception in the normal lower extremity and in the tarsal tunnel syndrome. Muscle Nerve 19: 285, 1996.
38. Tassler, P. L., and Dellon, A. L. Correlation of measurements of pressure perception using the pressure-specified sensory device with electrodiagnostic testing. J. Occup. Environ. Med. 37: 862, 1995.
39. Wiles, P. G., Pearce, S. M., Rice, P. J., et al. Vibration perception threshold: Influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet. Med. 8: 157, 1991.
40. Valdivia, J. M., Dellon, A. L., Weinand, M. E., et al. Surgical treatment of peripheral neuropathy: Outcomes from 100 consecutive decompressions. J. Am. Podiatr. Med. Assoc. 95: 451, 2005.
41. Nazimek-Siewniak, B., Moczulski, D., and Grzeszczak, W. Risk of macrovascular and microvascular complications in type 2 diabetes: Results of longitudinal study design. J. Diabetes Complications 16: 271, 2002.
42. Rodrigues, T. C., Pecis, M., Azevedo, M. J., et al. [Blood pressure homeostasis and microvascular complications in diabetic patients.] Arq. Bras. Endocrinol. Metabol. 49: 882, 2005.
43. Dolan, N. C., Liu, K., Criqui, M. H., et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25: 113, 2002.
44. McDaniel, M. D., and Cronenwett, J. L. Basic data related to the natural history of intermittent claudication. Ann. Vasc. Surg. 3: 273, 1989.
45. Gregg, E. W., Sorlie, P., Paulose-Ram, R., et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 27: 1591, 2004.
46. Mousa, A., Rhee, J. Y., Trocciola, S. M., et al. Percutaneous endovascular treatment for chronic limb ischemia. Ann. Vasc. Surg. 19: 186, 2005.
47. Trocciola, S. M., Chaer, R., Dayal, R., et al. Comparison of results in endovascular interventions for infrainguinal lesions: Claudication versus critical limb ischemia. Am. Surg. 71: 474, 2005.
48. Laird, J. R., Zeller, T., Gray, B. H., et al. Following laser-assisted angioplasty for critical limb ischemia: Results of the LACI Multicenter Trial. J. Endovasc. Ther. 13: 1, 2006.
49. Bosiers, M., Peeters, P., Elst, F. V., et al. Excimer laser assisted angioplasty for critical limb ischemia: Results of the LACI Belgium Study. Eur. J. Vasc. Endovasc. Surg. 29: 613, 2005.
50. Faglia, E., Mantero, M., Caminiti, M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: Clinical results of a multicentric study of 221 consecutive diabetic subjects. J. Intern. Med. 252: 225, 2002.
51. Ingle, H., Nasim, A., Bolia, A., et al. Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia: Long-term results. J. Endovasc. Ther. 9: 411, 2002.
52. Lapeyre, M., Kobeiter, H., Desgranges, P., et al. Assessment of critical limb ischemia in patients with diabetes: Comparison of MR angiography and digital subtraction angiography. A.J.R. Am. J. Roentgenol. 185: 1641, 2005.
53. Mostow, E. N. Diagnosis and classification of chronic wounds. Clin. Dermatol. 12: 3, 1994.
54. Robson, M. C., Mustoe, T. A., and Hunt, T. K. The future of recombinant growth factors in wound healing. Am. J. Surg. 176: 80S, 1998.
55. Lazarus, G. S., Cooper, D. M., Knighton, D. R., et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch. Dermatol. 130: 489, 1994.
56. O'Neill, M. S., Veves, A., Zanobetti, A., et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 111: 2913, 2005.
57. Economides, P. A., Khaodhiar, L., Caselli, A., et al. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes 54: 204, 2005.
58. Rodrigues, T. C., Pecis, M., Azevedo, M. J., et al. [Blood pressure homeostasis and microvascular complications in diabetic patients.] Arq. Bras. Endocrinol. Metabol. 49: 882, 2005.
59. Valeri, C., Pozzilli, P., and Leslie, D. Glucose control in diabetes. Diabetes Metab. Res. Rev. 20 (Suppl. 2): S1, 2004.
60. Roberts, S. R., and Hamedani, B. Benefits and methods of achieving strict glycemic control in the ICU. Crit. Care Nurs. Clin. North Am. 16: 537, 2004.
61. Goldstein, D. E., Little, R. R., Lorenz, R. A., et al. Tests of glycemia in diabetes. Diabetes Care 27 (Suppl. 1): S91, 2004.
62. Stratton, I. M., Adler, A. I., Neil, H. A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. B.M.J. 321: 405, 2000.
63. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977, 1993.
64. Keech, A., Simes, R. J., Barter, P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 366: 1849, 2005.
65. Krentz, A. J. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes. Metab. 5 (Suppl. 1): S19, 2003.
66. Fujiwara, T., Saitoh, S., Takagi, S., et al. Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia. Hypertens. Res. 28: 665, 2005.
67. Shetty, G. K., Economides, P. A., Horton, E. S., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450, 2004.
68. Cundiff, D. K., and Nigg, C. R. Diet and diabetic retinopathy: Insights from the Diabetes Control and Complications Trial (DCCT). MedGenMed 7: 3, 2005.
69. Carr, A. A., Kowey, P. R., Devereux, R. B., et al. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am. J. Cardiol. 96: 1530, 2005.
70. Waitzberg, D. L., and Correia, M. I. Nutritional assessment in the hospitalized patient. Curr. Opin. Clin. Nutr. Metab. Care 6: 531, 2003.
71. Marcos, A., Nova, E., and Montero, A. Changes in the immune system are conditioned by nutrition. Eur. J. Clin. Nutr. 57 (Suppl. 1): S66, 2003.
72. Frykberg, R. G. A summary of guidelines for managing the diabetic foot. Adv. Skin Wound Care 18: 209, 2005.
73. Lansdown, A. B. Nutrition 2: A vital consideration in the management of skin wounds. Br. J. Nurs. 13: 1199, 2004.
74. Collins, N. Protein-energy malnutrition and involuntary weight loss: Nutritional and pharmacological strategies to enhance wound healing. Expert Opin. Pharmacother. 4: 1121, 2003.
75. Guerrero-Romero, F., and Rodriguez-Moran, M. Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J. Diabetes Complications 12: 193, 1998.
76. Nathan, D. M., Cleary, P. A., Backlund, J. Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353: 2643, 2005.
77. Gall, M. A., Rossing, P., Skott, P., et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 655, 1991.
78. Gupta, A. K., Konnikov, N., MacDonald, P., et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br. J. Dermatol. 139: 665, 1998.
79. Bristow, I. R., and Baran, R. Topical and oral combination therapy for toenail onychomycosis: An updated review. J. Am. Podiatr. Med. Assoc. 96: 116, 2006.
80. Drake, L. A., Patrick, D. L., Fleckman, P., et al. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J. Am. Acad. Dermatol. 41: 189, 1999.
81. Gupta, A. K., and Humke, S. The prevalence and management of onychomycosis in diabetic patients. Eur. J. Dermatol. 10: 379, 2000.
82. Rich, P. Onychomycosis and tinea pedis in patients with diabetes. J. Am. Acad. Dermatol. 43: S130, 2000.
83. Robbins, J. M. Treatment of onychomycosis in the diabetic patient population. J. Diabetes Complications 17: 98, 2003.
84. Bell-Syer, S. E., Hart, R., Crawford, F., et al. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst. Rev. CD003584, 2002.
85. Gupta, A. K., Einarson, T. R., Summerbell, R. C., et al. An overview of topical antifungal therapy in dermatomycoses: A North American perspective. Drugs 55: 645, 1998.
86. Del Rosso, J. Q. Advances in the treatment of superficial fungal infections: Focus on onychomycosis and dry tinea pedis. J. Am. Osteopath. Assoc. 97: 339, 1997.
87. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26: 3333, 2003.
88. Eldrup, N., Sillesen, H., Prescott, E., et al. Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis. Eur. Heart J. 27: 316, 2006.
89. Khan, N. A., Rahim, S. A., Anand, S. S., et al. Does the clinical examination predict lower extremity peripheral arterial disease? J.A.M.A. 295: 536, 2006.
90. Sumpio, B. E., Lee, T., and Blume, P. A. Vascular evaluation and arterial reconstruction of the diabetic foot. Clin. Podiatr. Med. Surg. 20: 689, 2003.
91. Andros, G. Diagnostic and therapeutic arterial interventions in the ulcerated diabetic foot. Diabetes Metab. Res. Rev.. 20 (Suppl. 1): S29, 2004.
92. Pomposelli, F. B., Jr., Marcaccio, E. J., Gibbons, G. W., et al. Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus. J. Vasc. Surg. 21: 375, 1995.
93. Dorweiler, B., Neufang, A., Kreitner, K. F., et al. Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J. Vasc. Surg. 35: 766, 2002.
94. Kreitner, K. F., Kalden, P., Neufang, A., et al. Diabetes and peripheral arterial occlusive disease: Prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. A.J.R. Am. J. Roentgenol. 174: 171, 2000.
95. Pinzur, M. S., Slovenkai, M. P., Trepman, E., et al. Guidelines for diabetic foot care: Recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society. Foot Ankle Int. 26: 113, 2005.
96. Colagiuri, S., Marsden, L. L., Naidu, V., et al. The use of orthotic devices to correct plantar callus in people with diabetes. Diabetes Res. Clin. Pract. 28: 29, 1995.
97. Jensen, J. A., Goodson, W. H., Hopf, H. W., et al. Cigarette smoking decreases tissue oxygen. Arch. Surg. 126: 1131, 1991.
98. Sorensen, L. T., Nielsen, H. B., Kharazmi, A., et al. Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes. Surgery 136: 1047, 2004.
99. Gottrup, F. Oxygen in wound healing and infection. World J. Surg. 28: 312, 2004.
100. Newman, L. G., Waller, J., Palestro, C. J., et al. Unsuspected osteomyelitis in diabetic foot ulcers: Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J.A.M.A. 266: 1246, 1991.
101. Lew, D. P., and Waldvogel, F. A. Osteomyelitis. Lancet 364: 369, 2004.
102. Tomas, M. B., Patel, M., Marwin, S. E., et al. The diabetic foot. Br. J. Radiol. 73: 443, 2000.
103. Bonham, P. A critical review of the literature: Part I. Diagnosing osteomyelitis in patients with diabetes and foot ulcers. J. Wound Ostomy Continence Nurs. 28: 73, 2001.
104. Levine, S. E., Neagle, C. E., Esterhai, J. L., et al. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot Ankle Int. 15: 151, 1994.
105. Lipman, B. T., Collier, B. D., Carrera, G. F., et al. Detection of osteomyelitis in the neuropathic foot: Nuclear medicine, MRI and conventional radiography. Clin. Nucl. Med. 23: 77, 1998.
106. Vesco, L., Boulahdour, H., Hamissa, S., et al. The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients. Metabolism 48: 922, 1999.
107. Balsells, M., Viade, J., Millan, M., et al. Prevalence of osteomyelitis in non-healing diabetic foot ulcers: Usefulness of radiologic and scintigraphic findings. Diabetes Res. Clin. Pract. 38: 123, 1997.
108. Jay, P. R., Michelson, J. D., Mizel, M. S., et al. Efficacy of three-phase bone scans in evaluating diabetic foot ulcers. Foot Ankle Int. 20: 347, 1999.
109. Palestro, C. J., and Torres, M. A. Radionuclide imaging in orthopedic infections. Semin. Nucl. Med. 27: 334, 1997.
110. Becker, W. Imaging osteomyelitis and the diabetic foot. Q. J. Nucl. Med. 43: 9, 1999.
111. Di Gregorio, F., Bray, A., Pedicelli, A., et al. Diagnostic imaging of the diabetic foot. Rays 22: 550, 1997.
112. Kumar, V. Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q. J. Nucl. Med. Mol. Imaging 49: 325, 2005.
113. Berendt, A. R., and Lipsky, B. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot. Curr. Diab. Rep. 4: 424, 2004.
114. Termaat, M. F., Raijmakers, P. G., Scholten, H. J., et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis. J. Bone Joint Surg. Am. 87: 2464, 2005.
115. Wrobel, J. S., and Connolly, J. E. Making the diagnosis of osteomyelitis: The role of prevalence. J. Am. Podiatr. Med. Assoc. 88: 337, 1998.
116. Lipsky, B. A. Osteomyelitis of the foot in diabetic patients. Clin. Infect. Dis. 25: 1318, 1997.
117. Schinabeck, M. K., and Johnson, J. L. Osteomyelitis in diabetic foot ulcers: Prompt diagnosis can avert amputation. Postgrad. Med. 118: 11, 2005.
118. Sibbald, R. G., Williamson, D., Orsted, H. L., et al. Preparing the wound bed: Debridement, bacterial balance, and moisture balance. Ostomy Wound Manage. 46: 14, 2000.
119. Hess, C. T., and Kirsner, R. S. Orchestrating wound healing: Assessing and preparing the wound bed. Adv. Skin Wound Care. 16: 246, 2003.
120. Saap, L. J., and Falanga, V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen. 10: 354, 2002.
121. Abraham, Z., Lahat, N., Kinarty, A., et al. Psoriasis, necrobiosis lipodica, granuloma annulare, vitiligo and skin infections in the same diabetic patient. J. Dermatol. 7: 440, 1990.
122. Feige, U., and van Eden, W. Infection, autoimmunity and autoimmune disease. Exs 77: 359, 1996.
123. American Diabetes Association. Consensus development conference on diabetic foot wound care, 7-8 April 1999, Boston, Massachusetts. Diabetes Care 22: 1354, 1999.
124. Lipsky, B. A. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab. Res. Rev. 20 (Suppl. 1): S68, 2004.
125. Senneville, E., Melliez, H., Beltrand, E., et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures. Clin. Infect. Dis. 42: 57, 2006.
126. Pellizzer, G., Strazzabosco, M., Presi, S., et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet. Med. 18: 822, 2001.
127. Kessler, L., Piemont, Y., Ortega, F., et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet. Med. 23: 99, 2006.
128. Jeffcoate, W. J., and Lipsky, B. A. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin. Infect. Dis. 39 (Suppl. 2): S115, 2004.
129. Stephens, P., Wall, I. B., Wilson, M. J., et al. Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br. J. Dermatol. 148: 456, 2003.
130. White, R. J., Cooper, R., and Kingsley, A. Wound colonization and infection: The role of topical antimicrobials. Br. J. Nurs. 10: 563, 2001.
131. Armstrong, D. G., Nguyen, H. C., Lavery, L. A., et al. Off-loading the diabetic foot wound: A randomized clinical trial. Diabetes Care 24: 1019, 2001.
132. Lobmann, R., Kayser, R., Kasten, G., et al. Effects of preventative footwear on foot pressure as determined by pedobarography in diabetic patients: A prospective study. Diabet. Med. 18: 314, 2001.
133. Hartsell, H. D., Brand, R. A., Frantz, R. A., et al. The effects of total contact casting materials on plantar pressures. Foot Ankle Int. 25: 73, 2004.
134. Armstrong, D. G., Short, B., Espensen, E. H., et al. Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers. J. Am. Podiatr. Med. Assoc. 92: 405, 2002.
135. Katz, I. A., Harlan, A., Miranda-Palma, B., et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 28: 555, 2005.
136. Cavanagh, P. R., Lipsky, B. A., Bradbury, A. W., et al. Treatment for diabetic foot ulcers. Lancet 366: 1725, 2005.
137. Zimny, S., Schatz, H., and Pfohl, M. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers. Exp. Clin. Endocrinol. Diabetes 112: 191, 2004.
138. Robson, M. C., Hill, D. P., Woodske, M. E., et al. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch. Surg. 135: 773, 2000.
139. Brem, H., Balledux, J., Sukkarieh, T., et al . Healing of venous ulcers of long duration with a bilayered living skin substitute: Results from a general surgery and dermatology department. Dermatol. Surg. 27: 915, 2001.
140. Brem, H. Specific paradigm for wound bed preparation in chronic wounds. In G. W. Cherry, K. G. Harding, and T. J. Ryan, Wound Bed Preparation. London: Royal Society of Medicine Press Ltd., 2001. Pp. 33-39.
141. Schultz, G. S., Sibbald, R. G., Falanga, V., et al. Wound bed preparation: A systematic approach to wound management. Wound Repair Regen. 11 (Suppl. 1): S1, 2003.
142. Wright, J. B., Lam, K., and Burrell, R. E. Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am. J. Infect. Control. 26: 572, 1998.
143. Zhou, L. H., Nahm, W. K., Badiavas, E., et al. Slow release iodine preparation and wound healing: In vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br. J. Dermatol. 146: 365, 2002.
144. Svensjo, T., Pomahac, B., Yao, F., et al. Accelerated healing of full-thickness skin wounds in a wet environment. Plast. Reconstr. Surg. 106: 602, 2000.
145. Allie, D. E., Hebert, C. J., Lirtzman, M. D., et al. Novel treatment strategy for leg and sternal wound complications after coronary artery bypass graft surgery: Bioengineered Apligraf. Ann. Thorac. Surg. 78: 673, 2004.
146. Veves, A., Falanga, V., Armstrong, D. G., et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 24: 290, 2001.
147. Brem, H., Young, J., Tomic-Canic, M., et al. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg. Technol. Int. 11: 23, 2003.
148. Langemo, D. K. Venous ulcers: Etiology and care of patients treated with human skin equivalent grafts. J. Vasc. Nurs. 17: 6, 1999.
149. Gath, H. J., Hell, B., Zarrinbal, R., et al. Regeneration of intraoral defects after tumor resection with a bioengineered human dermal replacement (Dermagraft). Plast. Reconstr. Surg. 109: 889, 2002.
150. Embil, J. M., Papp, K., Sibbald, G., et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy. Wound Repair Regen. 8: 162, 2000.
151. Wieman, T. J. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group Am. J. Surg 176: 74S, 1998.
152. Wieman, T. J., Smiell, J. M., and Su, Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled double-blind study. Diabetes Care 21: 822, 1998.
153. Armstrong, D. G., Lavery, L. A. Negative pressure wound therapy after partial diabetic foot amputation: A multicentre, randomised controlled trial. Lancet 366: 1704, 2005.
154. Eginton, M. T., Brown, K. R., Seabrook, G. R., et al. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann. Vasc. Surg. 17: 645, 2003.
155. Armstrong, D. G., Kunze, K., Martin, B. R., et al. Plantar pressure changes using a novel negative pressure wound therapy technique. J. Am. Podiatr. Med. Assoc. 94: 456, 2004.
156. Puttirutvong, P. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. J. Med. Assoc. Thai. 87: 66, 2004.
157. Silverstein, G. Dermal regeneration template in the surgical management of diabetic foot ulcers: A series of five cases. J. Foot Ankle Surg. 45: 28, 2006.
158. Baumeister, S., Dragu, A., Jester, A., et al. [The role of plastic and reconstructive surgery within an interdisciplinary treatment concept for diabetic ulcers of the foot.] Dtsch. Med. Wochenschr. 129: 676, 2004.
159. Attinger, C. E., Ducic, I., Cooper, P., et al. The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients. Plast. Reconstr. Surg. 110: 1047, 2002.
160. Gottrup, F. A specialized wound-healing center concept: Importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am. J. Surg. 187: 38S, 2004.
161. Gottrup, F. Optimizing wound treatment through health care structuring and professional education. Wound Repair Regen. 12: 129, 2004.